Company intelligence / Profile preview
Thornton & Ross
- Ownership
- Private
- Development stage
- Commercial
Overview
Thornton & Ross has a broad commercial portfolio including leading UK consumer healthcare brands and prescription medicines. The company has expanded into specialty pharmaceuticals and biosimilars with recent launches such as the ustekinumab biosimilar Uzpruvo for Crohn’s disease and ulcerative colitis; ranibizumab biosimilar XIMLUCI for ophthalmic indications; teriparatide biosimilar MOVYMIA for osteoporosis; Kinpeygo for IgA nephropathy; and Fixkoh Airmaster inhaler for asthma/COPD. The company also maintains strong sales of established OTC brands like Covonia cough medicine.
- Therapeutic areas
- GastroenterologyPulmonologyCardiovascularPsychiatryMen's HealthMetabolic DisordersNephrologyOphthalmologyEndocrinologyImmunologyDermatologyOncologyNeurologyInfectious Diseases
- Modalities
- Small molecule (e.g., generics, OTC drugs)Biologic (biosimilars such as ustekinumab, ranibizumab, teriparatide)Device (inhalers for respiratory diseases)
- Industry
- Biotech
Drug pipeline
12 assets11 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Thornton & Ross.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Thornton & Ross.